Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice

Neuroscience Letters

Volumn 515, Issue 1, 2012, Pages 50-54

  Corrigan, Frances ^a,b   Vink, Robert ^a,b   Blumbergs, Peter C ^a,b   Masters, Colin L ^c   Cappai, Roberto ^d   van den Heuvel, Corinna ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANSON INSTITUTE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amyloid precursor protein; SAPP ; Traumatic brain injury

Indexed keywords

AMYLOID PRECURSOR PROTEIN; SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; CORTICAL IMPACT INJURY; HIPPOCAMPUS; MALE; MOTOR SYSTEM; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DRUG EVALUATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 84859441148     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.017     Document Type: Article

References (34)

1. Bell K.F., Zheng L., Fahrenholz F., Cuello A.C. ADAM-10 over-expression increases cortical synaptogenesis. Neurobiol. Aging 2006.
2. Bhasin R., Van Nostrand W.E., Saitoh T., Donets M.A., Barnes E.A., Quitschke W.W., Goldgaber D. Expression of active secreted forms of human amyloid beta-protein precursor by recombinant baculovirus-infected insect cells. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10307-10311.
3. Bramlett H.M., Dietrich W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 2004, 24:133-150.
4. Cheng G., Yu Z., Zhou D., Mattson M.P. Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein. Exp. Neurol. 2002, 175:407-414.
5. Clausen F., Hanell A., Bjork M., Hillered L., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2009, 30:385-396.
6. Corrigan F., Pham C.L., Vink R., Blumbergs P.C., Masters C.L., van den Heuvel C., Cappai R. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res. 2011, 1378:137-143.
7. Enriquez P., Bullock R. Molecular and cellular mechanisms in the pathophysiology of severe head injury. Curr. Pharm. Des. 2004, 10:2131-2143.
8. Fujimoto S.T., Longhi L., Saatman K.E., Conte V., Stocchetti N., McIntosh T.K. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci. Biobehav. Rev. 2004, 28:365-378.
9. Furukawa K., Mattson M.P. Secreted amyloid precursor protein alpha selectively suppresses N-methyl-d-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 1998, 83:429-438.
10. Furukawa K., Sopher B.L., Rydel R.E., Begley J.G., Pham D.G., Martin G.M., Fox M., Mattson M.P. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 1996, 67:1882-1896.
11. Gaetz M. The neurophysiology of brain injury. Clin. Neurophysiol. 2004, 115:4-18.
12. Goodman Y., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 1994, 128:1-12.
13. Hall E.D., Bryant Y.D., Cho W., Sullivan P.G. Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 2008, 25:235-247.
14. Han X., Tong J., Zhang J., Farahvar A., Wang E., Yang J., Samadani U., Smith D.H., Huang J.H. Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice. J. Neurotrauma 2011.
15. Henry A., Masters C.L., Beyreuther K., Cappai R. Expression of human amyloid precursor protein ectodomains in Pichia pastoris: analysis of culture conditions, purification, and characterization. Protein Expr. Purif. 1997, 10:283-291.
16. Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G., Kobusingye O.C. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 2007, 22:341-353.
17. Koopmans G., Blokland A., van Nieuwenhuijzen P., Prickaerts J. Assessment of spatial learning abilities of mice in a new circular maze. Physiol. Behav. 2003, 79:683-693.
18. Kupina N.C., Detloff M.R., Bobrowski W.F., Snyder B.J., Hall E.D. Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury. Exp. Neurol. 2003, 180:55-73.
19. Longhi L., Perego C., Ortolano F., Zanier E.R., Bianchi P., Stocchetti N., McIntosh T.K., De Simoni M.G. C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit. Care Med. 2009, 37:659-665.
20. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 1997, 77:1081-1132.
21. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993, 10:243-254.
22. Mbye L.H., Singh I.N., Sullivan P.G., Springer J.E., Hall E.D. Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog. Exp. Neurol. 2008, 209:243-253.
23. Morales D.M., Marklund N., Lebold D., Thompson H.J., Pitkanen A., Maxwell W.L., Longhi L., Laurer H., Maegele M., Neugebauer E., Graham D.I., Stocchetti N., McIntosh T.K. Experimental models of traumatic brain injury: do we really need to build a better mousetrap?. Neuroscience 2005, 136:971-989.
24. O'Connor C., Heath D.L., Cernak I., Nimmo A.J., Vink R. Effects of daily versus weekly testing and pre-training on the assessment of neurologic impairment following diffuse traumatic brain injury in rats. J. Neurotrauma 2003, 20:985-993.
25. Ohsawa I., Takamura C., Kohsaka S. The amino-terminal region of amyloid precursor protein is responsible for neurite outgrowth in rat neocortical explant culture. Biochem. Biophys. Res. Commun. 1997, 236:59-65.
26. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2007, Academic Press, San Diego.
27. Roch J.M., Masliah E., Roch-Levecq A.C., Sundsmo M.P., Otero D.A., Veinbergs I., Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:7450-7454.
28. Siopi E., Cho A.H., Homsi S., Croci N., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Minocycline restores sAPPalpha levels and reduces the late histopathological consequences of traumatic brain injury in mice. J. Neurotrauma 2011.
29. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 1994, 63:781-784.
30. Stein T.D., Anders N.J., DeCarli C., Chan S.L., Mattson M.P., Johnson J.A. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J. Neurosci. 2004, 24:7707-7717.
31. Thornton E., Vink R., Blumbergs P.C., Van Den Heuvel C. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 2006, 1094:38-46.
32. Vink R., Van Den Heuvel C. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin. Investig. Drugs 2004, 13:1263-1274.
33. Wang Y., Ha Y. The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol. Cell 2004, 15:343-353.
34. You Z., Savitz S.I., Yang J., Degterev A., Yuan J., Cuny G.D., Moskowitz M.A., Whalen M.J. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J. Cereb. Blood Flow Metab. 2008, 28:1564-1573.